Cargando…
Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer
Autores principales: | Brüstle, Karina, Heidecker, Bettina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739719/ https://www.ncbi.nlm.nih.gov/pubmed/29290934 http://dx.doi.org/10.18632/oncotarget.22579 |
Ejemplares similares
-
Correction: Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer
por: Brüstle, Karina, et al.
Publicado: (2018) -
The Newest of Our Creeds
Publicado: (1878) -
The Newest of Our Creeds
por: Hodgkin,
Publicado: (1881) -
Cardiotoxicity Associated with Immune Checkpoint Inhibitors
por: Minegishi, Shintaro, et al.
Publicado: (2023) -
Drawbacks of the current practice
por: Agarwal, Ashok, et al.
Publicado: (2017)